What Every Geriatrician Needs to Know About Dementia Diagnostics and Treatment

Additional fee session

Co-Moderators: Jason Karlawish, MD & Esther S. Oh, MD, PhD

This pre-conference session provides practical, up-to-date guidance on the diagnosis, treatment, and prevention of dementia, with a focus on emerging Alzheimer’s disease therapeutics, biomarker use in primary care, and evolving care models. Expert faculty will explore the integration of AI and technology in dementia care and examine the diverse roles geriatricians play as primary care providers, dementia specialists, and interdisciplinary leaders. Learning Objectives: (1) summarize current and emerging pharmacologic therapies for Alzheimer’s disease, including indications, risks, and monitoring considerations; (2) describe key findings from dementia prevention research, including implications of the U.S. POINTER study for clinical practice; (3) evaluate the appropriate use, benefits, and limitations of dementia biomarkers in primary care settings; (4) compare models of dementia care delivery and identify strategies to improve care coordination and outcomes; (5) discuss the applications and ethical considerations of AI and technology in dementia diagnosis and management; and (6) define the evolving role of geriatricians in dementia care across the spectrum of practice, from primary care to subspecialty consultation.

Updates on Alzheimer’s Disease Therapeutics

Daniel C. Parker, MD 
 

Prevention: US Pointer Study
MaryJo L. Cleveland, MD 

Use of Biomarkers in Primary Care Clinics 
Cynthia M. Carlsson, MD, MS

Models of Dementia Care 
Mia Yang, MD

AI and Technology in Dementia Care 
Peter M. Abadir, MD 

Panel Discussion on Role of Geriatricians in Dementia Care - As Primary Care Physicians, As Dementia Specialists and Everything in Between
Alejandra Lopez, MD; Nathaniel A. Chin, MD; Lolita S. Nidadavolu, MD, PhD; Melissa Morgan-Gouveia, MD